Suppr超能文献

超重或肥胖青少年补充壳聚糖后肠道微生物群的变化:一项随机双盲临床试验。

Changes in gut microbiota following supplementation with chitosan in adolescents with overweight or obesity: a randomized, double-blind clinical trial.

作者信息

Fatahi Somaye, Sohouli Mohammad Hassan, Vahidshahi Koroush, Rohani Pejman, Safa Majid, Salehi Masoud, Găman Mihnea-Alexandru, Shidfar Farzad

机构信息

Department of Clinical Nutrition and Dietetics, Faculty of Nutrition and Food Technology, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Pediatric Gastroenterology and Hepatology Research Center, Pediatrics Centre of Excellence, Children'S Medical Center, Tehran University of Medical Sciences, Tehran, Iran.

出版信息

Diabetol Metab Syndr. 2025 Apr 8;17(1):120. doi: 10.1186/s13098-025-01681-0.

Abstract

BACKGROUND

Overweight and obesity have been associated with an altered intestinal microbiome. Recent investigations have demonstrated that fiber supplementation, including chitosan, can exert beneficial and protective effects on the composition of gut microbiota in humans diagnosed with overweight/obesity. However, there is still a great deal of heated debate regarding the impact of chitosan supplementation in overweight and obese adolescents. Therefore, the aim of this study is to clarify the effects of chitosan administration on the composition of the gut microbiome in overweight and obese adolescents.

METHODS AND ANALYSIS

Sixty-four overweight and obese adolescents were subjected to supplementation with 3 g of chitosan for 12 weeks. Anthropometric indices and physical activity were measured at the beginning and at the end of the intervention. After DNA extraction and purification, the quantity of bacteria in the patients' stool samples was determined by real-time polymerase chain reaction (PCR). The RCT was registered on the Iranian Registry of Clinical Trials ( www.irct.ir ) website (IRCT20091114002709 N57; registration date: 2021 - 06 - 20).

RESULTS

Individuals who received chitosan supplementation experienced a significant decrease in the BMI z-score (P < 0.001). Administration of chitosan led to notable significant decrease in the Firmicutes (P < 0.001) populations and the ratio of Firmicutes to Bacteroidetes (P < 0.001) as well as a notable increase in the Bacteroidetes (P = 0.008) and Akkermansia (P < 0.001) populations, respectively compare to control group. Mean changes in Lactobacillus populations were marginally significant (P = 0.05). Chitosan administration did not alter the composition in Bifidobacterium populations (P = 0.97).

CONCLUSION

The present study demonstrates beneficial effects of chitosan administration on some bacterial species associated with overweight and obesity in adolescents. Further research is needed to confirm our findings and clarify the impact of this intervention on the Lactobacillus population in the gut.

摘要

背景

超重和肥胖与肠道微生物群的改变有关。最近的研究表明,包括壳聚糖在内的纤维补充剂可以对被诊断为超重/肥胖的人的肠道微生物群组成产生有益和保护作用。然而,关于壳聚糖补充剂对超重和肥胖青少年的影响仍存在大量激烈的争论。因此,本研究的目的是阐明壳聚糖给药对超重和肥胖青少年肠道微生物群组成的影响。

方法与分析

64名超重和肥胖青少年接受了3克壳聚糖补充剂,为期12周。在干预开始和结束时测量人体测量指标和身体活动。在DNA提取和纯化后,通过实时聚合酶链反应(PCR)测定患者粪便样本中的细菌数量。该随机对照试验已在伊朗临床试验注册中心(www.irct.ir)网站上注册(IRCT20091114002709N57;注册日期:2021 - 06 - 20)。

结果

接受壳聚糖补充剂的个体的BMI z评分显著降低(P < 0.001)。壳聚糖给药导致厚壁菌门(P < 0.001)菌群以及厚壁菌门与拟杆菌门的比例(P < 0.001)显著降低,与对照组相比,拟杆菌门(P = 0.008)和阿克曼氏菌(P < 0.001)菌群显著增加。乳酸杆菌菌群的平均变化略有显著性(P = 0.05)。壳聚糖给药未改变双歧杆菌菌群的组成(P = 0.97)。

结论

本研究证明了壳聚糖给药对青少年中一些与超重和肥胖相关的细菌种类具有有益作用。需要进一步的研究来证实我们的发现,并阐明这种干预对肠道中乳酸杆菌菌群的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac9f/11978168/32b08e370382/13098_2025_1681_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验